English

Proven to help your memory…

Report this content

Memory Study showcased at the
Alzheimer's Association International Conference
on Alzheimer's Disease

An interview with neuroscience researcher Mark Underwood will help your audience understand the latest breakthrough in the fight against Alzheimer’s disease and other forms of dementia and the role jellyfish may have in providing hope to those with this devastating condition.

Quincy Bioscience has gone global with groundbreaking research from “The Madison Memory Study” – a 218 person double-blind placebo-controlled study demonstrating the jellyfish derived protein apoaequorin significantly improves cognitive function in people with memory concerns.

Quincy Bioscience presented the findings to the world’s leading Alzheimer’s researchers during the Alzheimer’s Association’s annual Alzheimer’s Association International Conference (AAIC) in Paris.

With almost 5.5 million Americans living with Alzheimer’s disease and millions more afflicted with related dementias, the memory disorder touches nearly every American. Health experts predict the coming wave of Baby Boomers with dementia will be a tidal wave crashing our health care system.

New approaches are badly needed with today’s approved Alzheimer’s medication offering little help to slow the progression of the disease.

Key research findings:

  • The double blind, placebo-controlled study of 218 adults demonstrated apoaequorin was able to significantly improve executive function, word recall, and short-term memory compared to placebo over 90 days.
  • The apoaequorin arm was able to reduce the total number of errors in a measure of cognitive function by 19 percent compared to baseline and significantly fewer errors than placebo.
  •  In a task requiring participants to learn a grocery shopping list, the apoaequorin group was able to recall significantly more items at Day 90 compared to baseline.

Quincy Bioscience is advancing Alzheimer’s research by utilizing a calcium-binding protein called apoaequorin which neutralizes excessive levels of calcium in the neurons that would otherwise destroy the cell.

“The Alzheimer’s research community has known for some time that unregulated calcium is a culprit.” explains Underwood. “There just haven’t been any solutions to address this cause. Our research is one very promising step which demonstrates that we can help people with memory concerns. Our next step is a larger scale study specifically targeting the Alzheimer’s population.   We are very hopeful based on these results.”

Eye opening facts about Alzheimer’s Disease:

  • Most people survive an average of four to eight years after an Alzheimer’s diagnosis, but some live as long as 20 years with the disease.
  • Alzheimer’s disease is the 5th leading cause of death in the United States for those aged 65 and older.
  • Deaths from Alzheimer have increased 66 percent between 2000 and 2008, while deaths from other major diseases, including the number one cause of death (heart disease), decreased.
  • By 2050, as many as 16 million Americans will have the disease.
  • Two-thirds of those with the disease are women.

SAMPLE INTERVIEW QUESTIONS

1. What type of conference is the AAIC?

2. What have you learned from your research? What kind of hope does it provide for the millions of baby boomers that are fearful of losing their memories?

3.   Apoaequorin is a protein that controls brain calcium concentration levels. How can this help people with dementia or Alzheimer’s?

4. How long will it be before this research is able to be applied and actually help people?
5. Where can listeners go to learn more information?

ABOUT MARK UNDERWOOD
Neuroscience researcher Mark Underwood president and co-founder of Quincy Bioscience, a biotech company located in Madison, Wisconsin focused on the discovery, development and commercialization of medicines to treat age related memory loss and the diseases of aging. 

Previous pre-clinical research demonstrating apoaequorin as a neuroprotectant has been presented to the Society of Neuroscience. Information related to this study can be found at http://quincybioscience.com/effects-of-apoaequorin/

Mark has informed and entertained listeners on some of the nation’s top talk radio shows including:  Mancow, Hugh Hewitt show and the Bev Smith show.  Mark has also been taped as an expert in the field of neuroscience for The Wall Street Journal Morning Radio, CBS and CNN Radio among others.

Warmest wishes,

Lisa Marie Roma
Public Relations Specialist

Quincy Bioscience
301 S Westfield St 200
Madison, WI 53717
Phone: 608-827-8155
Fax:608-833-0714